article Open AccessTop 1% cited
Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density
Cell · 1997 · Vol. 89(2) · pp. 309–319
W. Scott Simonet(Amgen (United States))Dave Lacey(Amgen (United States))Colin R. Dunstan(Amgen (United States))Michael J. Kelley(Amgen (United States))Ming‐Shi Chang(Amgen (United States))Roland Lüthy(Amgen (United States))Hung Q. Nguyen(Amgen (United States))Scott K. Wooden(Amgen (United States))L Bennett(Amgen (United States))Thomas C. Boone(Amgen (United States))Grant Shimamoto(Amgen (United States))M Rose(Amgen (United States))Robin Elliott(Amgen (United States))Anne Colombero(Amgen (United States))Hong‐Lin Tan(Amgen (United States))Geraldine Trail(Amgen (United States))John K. Sullivan(Amgen (United States))Elyse Davy(Amgen (United States))Nathan Bucay(Amgen (United States))Lisa Renshaw-Gegg(Amgen (United States))Tamar M. Hughes(Amgen (United States))David Hill(Amgen (United States))W Pattison(Amgen (United States))Pauline Campbell(Amgen (United States))Shane A. Sander(Amgen (United States))Gwyneth Van(Amgen (United States))J E Tarpley(Amgen (United States))Patricia L. Derby(Amgen (United States))R Lee(Amgen (United States))W.J Boyle✉(Amgen (United States))
Bone Metabolism and DiseasesAnimal Genetics and ReproductionRNA Research and SplicingOsteoprotegerinOsteoclastBone resorptionBiologyInternal medicineEndocrinologyReceptorOsteopetrosisIn vivoRecombinant DNA
MeSH terms
Amino Acid SequenceAnimalsBone ResorptionCell DifferentiationCells, CulturedFemaleGlycoproteinsCricetinaeHumansLiverMaleMice, TransgenicMolecular Sequence DataOrgan SpecificityOsteoclasts
Funding
- Amgen
Citations
5,099
FWCI
39.54
field-weighted impact
References
45
Percentile
100%
vs. same field & year
Citations per year
Cited by
RANK-RANKL-OPG: A current trends in orthodontic tooth movement and its role in accelerated orthodontics
International Journal of Applied Dental Sciences · 2022 · 3 citations
Vascular Calcification
Arteriosclerosis Thrombosis and Vascular Biology · 2004 · 853 citations
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
Proceedings of the National Academy of Sciences · 1998 · 4,244 citations
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
Endocrine Reviews · 2000 · 2,226 citations
The cell biology of osteoclast function
Journal of Cell Science · 2000 · 718 citations
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
Endocrine Reviews · 1999 · 2,264 citations
A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women
Journal of Bone and Mineral Research · 2004 · 762 citations
References
Modulation of Osteoclast Differentiation
Endocrine Reviews · 1992 · 1,012 citations
F4/80, a monoclonal antibody directed specifically against the mouse macrophage
European Journal of Immunology · 1981 · 1,604 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
